Publications - IR Sant Pau

Search

01/01/2025 Erosive Lesions in the Legs of an Elderly Woman

Carmona-Rocha, E, Rusiñol, L, Puig, L. Erosive Lesions in the Legs of an Elderly Woman. INDIAN JOURNAL OF DERMATOLOGY. 2025; 70(1)DOI:10.4103/ijd.ijd_851_23. PMID:39896302. IF:1.300(Q3/7D).

01/01/2025 Secukinumab for Treatment of Plaque Psoriasis in Real-World Clinical Practice in Spain: A Literature Review

Dauden, E, Ortiz-Salvador, JM, Notario, J, Puig, L, Santos-Juanes, J, Herrera-Acosta, E, Gomez-Labrador, L, Ruiz-Villaverde, R. Secukinumab for Treatment of Plaque Psoriasis in Real-World Clinical Practice in Spain: A Literature Review. Journal of Clinical Medicine. 2025; 14(2)DOI:10.3390/jcm14020478. PMID:39860484. IF:2.900(Q1/2D).

01/01/2025 Measurement Assessment of Minimal Disease Activity In Psoriasis in Spain: A National Cross-Sectional Study

Hernández, G, Martin, M, Alonso, S, Romero, I, Salvado, N, Farrés, M, Osuna, C, Bustínduy, M, de Araníbar, JG, Manresa, M, Velasco, M, Ferrer, A, Riesco, M, Genao, D, Ruíz-Villaverde, R, Boquete, L, Martínez, C, Rull, E, Descalzo, MA. Measurement Assessment of Minimal Disease Activity In Psoriasis in Spain: A National Cross-Sectional Study. Actas Dermo-Sifiliograficas. 2025; 116(1)DOI:10.1016/j.ad.2024.05.022. PMID:38876209. IF:(Q/D).

01/01/2025 Measurement Assessment of Minimal Disease Activity in Psoriasis in Spain: A National Cross-Sectional Study

Hernández, GC, Martín, MA, Alonso, SA, Romero, IB, Salvado, NE, Farrés, MF, Osuna, CG, Bustínduy, MG, de Aranibar, JGL, Manresa, MJ, Velasco, ML, Ferrer, AL, Riesco, MR, Genao, DR, Ruíz-Villaverde, R, Boquete, LS, Martínez, CS, Rull, EV, Descalzo, MA. Measurement Assessment of Minimal Disease Activity in Psoriasis in Spain: A National Cross-Sectional Study. Actas Dermo-Sifiliograficas. 2025; 116(1)DOI:10.1016/j.ad.2024.10.009. PMID:. IF:(Q/D).

01/01/2025 Infection Risk and Vaccination in the Management of Psoriasis: Considerations for Biologic Therapy

Mateu-Arrom, L, Puig, L. Infection Risk and Vaccination in the Management of Psoriasis: Considerations for Biologic Therapy. Psoriasis-Targets And Therapy. 2025; 15DOI:10.2147/PTT.S510141. PMID:40237012. IF:(Q/D).

31/12/2024 Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)

Girolomoni, G, Feldman, SR, Egeberg, A, Puig, L, Jung, J, Jung, H, Lee, Y. Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR). JOURNAL OF DERMATOLOGICAL TREATMENT. 2024; 35(1)DOI:10.1080/09546634.2024.2434091. PMID:39626886. IF:3.900(Q1/2D).

05/12/2024 Safety in patients with latent tuberculosis who received concomitant anti-tuberculosis medications: analysis of 11 studies of guselkumab in psoriatic disease

Puig, L, Tsai, TF, Soriano, ER, Bhutani, T, Miller, M, Kollmeier, AP, Li, S, You, Y, Li, HW, Patel, H, Lavie, F, Gooderham, M, Londono, A, Lebwohl, M, Nash, P. Safety in patients with latent tuberculosis who received concomitant anti-tuberculosis medications: analysis of 11 studies of guselkumab in psoriatic disease. BRITISH JOURNAL OF DERMATOLOGY. 2024; 191DOI:10.1093/bjd/ljae360.098. PMID:. IF:9.600(Q1/1D).

05/12/2024 Effectiveness of biologics in clinical practice: Month 12 absolute psoriasis area and severity index outcomes from an international observational Psoriasis Study of Health Outcomes

Maul, JT, Bonnekoh, B, Puig, L, McKenzie, R, Lampropoulou, A, Martimianaki, G, Fotiou, K, Pinter, A, Akiror, C. Effectiveness of biologics in clinical practice: Month 12 absolute psoriasis area and severity index outcomes from an international observational Psoriasis Study of Health Outcomes. BRITISH JOURNAL OF DERMATOLOGY. 2024; 191DOI:10.1093/bjd/ljae360.093. PMID:. IF:9.600(Q1/1D).

01/11/2024 An emerging epidemic of allergic contact dermatitis due to phytonadione epoxide (oxidised vitamin K1)

Gatica-Ortega, ME, Pastor-Nieto, MA, Giménez-Arnau, AM, Mercader-García, P, Serra-Baldrich, E, Zaragoza-Ninet, V, Sanz-Sánchez, T, Sánchez-Gilo, A, Pesqué, D, Tous-Romero, F, Ortiz-de-Frutos, FJ, de la Rosa-Fernández, E, Dorta-Alom, S, Elosua-González, M, Gonzalez-Perez, R, Carrascosa-Carrillo, JM, Munera-Campos, M, Silvestre-Salvador, JF, Miquel-Miquel, J, Minguez, AD, Borrego, L. An emerging epidemic of allergic contact dermatitis due to phytonadione epoxide (oxidised vitamin K1). CONTACT DERMATITIS. 2024; 91(5)DOI:10.1111/cod.14675. PMID:39164011. IF:4.600(Q1/1D).

01/11/2024 [Translated article] Consensus on the Diagnostic Algorithm for Chronic Nodular Prurigo

Frutos, JOD, Baldrich, ES, Boixareu, MJT, Hita, JCA, Carrillo, JMC, Nart, IF, Flórez, A, Pinto, PH, Silvestre, JF. [Translated article] Consensus on the Diagnostic Algorithm for Chronic Nodular Prurigo. Actas Dermo-Sifiliograficas. 2024; 115(10)DOI:10.1016/j.ad.2024.09.011. PMID:39260612. IF:(Q/D).

01/11/2024 Four-year maintenance of complete skin clearance with bimekizumab in 10 Spanish patients from the BE RADIANT trial

Ferrer, AL, Romero, IB, Díaz, RR, Pinto, PH. Four-year maintenance of complete skin clearance with bimekizumab in 10 Spanish patients from the BE RADIANT trial. Actas Dermo-Sifiliograficas. 2024; 115(10)DOI:10.1016/j.ad.2023.05.044. PMID:39033804. IF:(Q/D).

01/11/2024 Consensus on the Diagnostic Algorithm for Chronic Nodular Prurigo

de Frutos, JO, Baldrich, ES, Boixareu, MJT, Hita, JCA, Carrillo, JMC, Nart, IF, Menéndez, AF, Pinto, PH, Silvestre, JF. Consensus on the Diagnostic Algorithm for Chronic Nodular Prurigo. Actas Dermo-Sifiliograficas. 2024; 115(10)DOI:10.1016/j.ad.2024.03.035. PMID:38663729. IF:(Q/D).

01/11/2024 Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)

Chicharro, P, Munera-Campos, M, Zaragoza-Ninet, V, Giménez-Arnau, A, González-Pérez, R, Miquel-Miquel, FJ, Córdoba-Guijarro, S, Sanz-Sánchez, T, Ruiz-González, I, Silvestre-Salvador, JF, Serra-Baldrich, E, Borrego, L, Pastor-Nieto, MA, de Frutos, FJO, Mercader-García, P, Heras-Mendaza, F, Fernández-Redondo, V, Rodríguez-Serna, M, Hervella-García, M, Carrascosa, JM, Gallego-Descalzo, MA, García-Doval, I, Sánchez-Pérez, J. Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC). CONTACT DERMATITIS. 2024; 91(5)DOI:10.1111/cod.14672. PMID:39138883. IF:4.600(Q1/1D).

30/10/2024 Dupilumab treatment in paediatric atopic dermatitis (2-18 years): Spanish multicentre retrospective real-world study

Iznardo, H, Roé, E, Vicente, A, Prat, C, Casals, M, Martín-Santiago, A, Esteve, A, Viñas, M, Munera-Campos, M, Corella, F, Mollet, J, Figueras-Nart, I, Vila, A, Soria, X, Azón-Masoliver, A, Marqués-Martín, L, Nadal-Lladó, C, Bel, S, Pujol-Montcusí, J, Bertolín-Colilla, M, Curto-Barredo, L, Melé-Ninot, G, Evole, M, Berbegal, L, Puig, L, Baselga, E. Dupilumab treatment in paediatric atopic dermatitis (2-18 years): Spanish multicentre retrospective real-world study. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2024; 50(1)DOI:10.1093/ced/llae300. PMID:39093288. IF:2.800(Q2/4D).

02/10/2024 Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies

Schwartzman, S, Puig, L, Cohen, AD, Khattri, S, Jossart, C, Diaz, C, Garrelts, A, Ngantcha, M, Eberhart, N, Eleftheriadi, A, Tangsirisap, N, Schuster, C, Gottlieb, AB. Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies. Expert Opinion On Drug Safety. 2024; 23(10)DOI:10.1080/14740338.2024.2399092. PMID:39234767. IF:3.100(Q2/4D).

01/10/2024 Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic Disease

Stolnicki, DK, Coates, LC, Gollins, CE, Koppikar, S, Perez-Chada, LM, Puig, L, Ogdie, A, Deodhar, A, Ritchlin, C, Hwang, ST, Goldenstein-Schainberg, C. Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic Disease. JOURNAL OF RHEUMATOLOGY. 2024; 51DOI:10.3899/jrheum.2024-0621. PMID:39089830. IF:3.400(Q2/3D).

01/09/2024 Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial

Puig, L, Costanzo, A, de Jong, EMGJ, Torres, T, Warren, RB, Wapenaar, R, Wegner, S, Gorecki, P, Gramiccia, T, Jazra, M, Buyze, J, Conrad, C. Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial. Dermatology and Therapy. 2024; 14(9)DOI:10.1007/s13555-024-01245-6. PMID:39153060. IF:4.200(Q1/1D).

01/09/2024 A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study

Puig, L, Belloso, RI, Rivera-Díaz, R, Sánchez, JM, Fernández-Freire, LR, Sahuquillo-Torralba, A, Ruiz-Villaverde, R. A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study. DERMATOLOGY. 2024; 240(5-6)DOI:10.1159/000540019. PMID:39019021. IF:2.700(Q2/4D).

01/09/2024 Safety in Patients with Latent Tuberculosis Who Received Concomitant Anti-Tuberculosis Medications: Analysis of 11 Studies of Guselkumab in Psoriatic Disease

Puig, L, Tsai, TF, Soriano, ER, Bhutani, T, Miller, M, Kollmeier, AP, Li, S, You, Y, Petrick, M, Li, HW, Patel, H, Lavie, F, Gooderham, M, Londo o, A, Lebwohl, M, Nash, P. Safety in Patients with Latent Tuberculosis Who Received Concomitant Anti-Tuberculosis Medications: Analysis of 11 Studies of Guselkumab in Psoriatic Disease. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Bimekizumab Efficacy and Safety Through 4 Years in Moderate to Severe Plaque Psoriasis: Long-Term Results from a Phase 3 Study and Open-Label Extension

Tha i, D, Puig, L, Merola, JF, Jullien, D, Costanzo, A, Wang, M, Deherder, D, Pinto, JML, Lebwohl, M. Bimekizumab Efficacy and Safety Through 4 Years in Moderate to Severe Plaque Psoriasis: Long-Term Results from a Phase 3 Study and Open-Label Extension. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions

Ständer, S, Pereira, MP, Zeidler, C, Legat, FJ, Misery, L, Loenndahl, L, Bewley, AP, Brenaut, E, Bobko, S, Elberling, J, Evers, AWM, Garcovich, S, Gieler, U, Goncalo, M, Kupfer, J, Lambert, J, Lvov, A, Metz, M, Michenko, A, Papadavid, E, Reich, A, Savk, E, Schneider, G, Schut, C, Serra-Baldrich, E, Ständer, HF, Szepietowski, JC, Wallengren, J, Weisshaar, E, Augustin, M. EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024; 38(9)DOI:10.1111/jdv.20102. PMID:38738586. IF:8.000(Q1/1D).

08/08/2024 Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis

Silverberg, JI, Bieber, T, Paller, A, Beck, LA, Kamata, M, Puig, L, Wiseman, M, Ezzedine, K, Foley, P, Johansson, E, Dossenbach, M, Akmaz, B, Casillas, M, Karlsson, A, Chovatiya, R. Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis. BRITISH JOURNAL OF DERMATOLOGY. 2024; 191DOI:10.1093/bjd/ljae266.014. PMID:. IF:9.600(Q1/1D).

03/08/2024 Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, trials

Bissonnette, R, Warren, RB, Pinter, A, Agner, T, Gooderham, M, Schuttelaar, MLA, Crépy, MN, Stingeni, L, Serra-Baldrich, E, Baranowski, K, Korn, S, Kurvits, M, Plohberger, U, Vest, NS, Schliemann, S. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, trials. LANCET. 2024; 404(10451)DOI:10.1016/S0140-6736(24)01027-4. PMID:39033766. IF:88.500(Q1/1D).

01/08/2024 Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search

Puig, L, Fujita, H, Thaçi, D, Zheng, M, Daly, ACH, Leonardi, C, Lebwohl, MG, Barker, J. Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search. Dermatology and Therapy. 2024; 14(9)DOI:10.1007/s13555-024-01230-z. PMID:39088126. IF:4.200(Q1/1D).

01/08/2024 Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice

Butrón-Bris, B, Llamas-Velasco, M, Ovejero-Benito, MC, Santos-Juanes, J, Martínez-López, A, Ruiz-Villaverde, R, Roustan, G, Baniandrés, O, Izu-Belloso, R, de la Cueva, P, Sahuquillo-Torralba, A, Gónzalez-Quesada, A, Vilarrasa-Rull, E, Pujol-Montcusi, J, García-Martínez, J, Navares, M, Palomar-Moreno, I, Novalbos, J, Abad-Santos, F, Daudén, E, de la Fuente, H. Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice. EXPERIMENTAL DERMATOLOGY. 2024; 33(8)DOI:10.1111/exd.15152. PMID:39081053. IF:3.100(Q2/3D).

01/08/2024 A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets

Rusinol, L, Puig, L. A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(15)DOI:10.3390/ijms25158437. PMID:39126010. IF:4.900(Q1/3D).

01/08/2024 Lentigo maligna: a comprehensive review on diagnosis and treatment

Carmona-Rocha, E, Rusiñol, L, Garcia-Melendo, C, Iznardo, H, Mozos, A, López-Sánchez, C, Yélamos, O. Lentigo maligna: a comprehensive review on diagnosis and treatment. Italian Journal of Dermatology and Venereology. 2024; 159(4)DOI:10.23736/S2784-8671.24.07837-X. PMID:39069838. IF:2.600(Q2/4D).

17/07/2024 International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council

Choon, SE, van de Kerkhof, P, Gudjonsson, JE, de la Cruz, C, Barker, J, Morita, A, Romiti, R, Affandi, AM, Asawanonda, P, Burden, AD, Gonzalez, C, Marrakchi, S, Mowla, MR, Okubo, Y, Oon, HH, Terui, T, Tsai, TF, Callis-Duffin, K, Fujita, H, Jo, SJ, Merola, J, Mrowietz, U, PUIG SANZ, LUIS, Thaçi, D, Velásquez, M, Augustine, M, El Sayed, M, Navarini, AA, Pink, A, Prinz, J, Turki, H, Magalhaes, R, Capon, F, Bachelez, H. International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council. JAMA Dermatology. 2024; DOI:10.1001/jamadermatol.2024.0915. PMID:38691347. IF:11.000(Q1/1D).

01/07/2024 Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis

Puig, L, Notario, J, López-Ferrer, A, Scheneller-Pavelescu, L, Pérez, B, Galache, C, de la Cueva, P, Carrascosa, JM. Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis. Actas Dermo-Sifiliograficas. 2024; 115(7)DOI:10.1016/j.ad.2024.02.013. PMID:38382743. IF:(Q/D).

01/07/2024 Validation of the Spanish Version of the PURE-4 Questionnaire for the Early Detection of Psoriatic Arthritis in Psoriatic Patients

Belinchón-Romero, I, López-Ferrer, A, Farrés, MFI, Rivera-Díaz, R, Vidal-Sarro, D, Fernández-Freire, LR, de la Cueva-dobao, P, Santos-Juanes, J, Rocamora-Durán, V, Martín-Vázquez, V, Gómez-Labradror, L, Queiro-Silva, R. Validation of the Spanish Version of the PURE-4 Questionnaire for the Early Detection of Psoriatic Arthritis in Psoriatic Patients. Actas Dermo-Sifiliograficas. 2024; 115(7)DOI:10.1016/j.ad.2024.05.010. PMID:38815678. IF:(Q/D).

01/07/2024 Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)

Navarro-Triviño, FJ, Borrego, L, Silvestre-Salvador, JF, Mercader-García, P, Giménez-Arnau, AM, Frutos, FJOD, Sanz-Sánchez, T, Melé-Ninot, G, Sánchez-Gilo, A, Zaragoza-Ninet, V, Serra-Baldrich, E, Miquel-Miquel, J, Córdoba-Guijarro, S, Rodríguez-Serna, M, Ruíz-González, I, Carrascosa-Carrillo, JM, de la Fuente, EG, Pastor-Nieto, MA, Heras-Mendaza, F, González-Pérez, R, Guillén, PSP, Sánchez-Pérez, J, Gatica-Ortega, ME, Fernández-Redondo, V, Hervella-Garcés, M, Manrique-Martínez, P, Guimaraens-Juanena, D, García-Gavín, J, Giménez-Arnau, E, Figueras-Nart, I, Curto-Barredo, L, Armario-Hita, JC. Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC). Actas Dermo-Sifiliograficas. 2024; 115(7)DOI:10.1016/j.ad.2024.03.024. PMID:38556197. IF:(Q/D).

01/07/2024 Epicensus: The Drive to Elevating the Standard of Care for Patients with Psoriasis

Thomsen, SF, Corazza, V, Augustin, M, Lazaridou, E, Puig, L, Guillevin, L. Epicensus: The Drive to Elevating the Standard of Care for Patients with Psoriasis. Dermatology and Therapy. 2024; 14(7)DOI:10.1007/s13555-024-01192-2. PMID:38896383. IF:4.200(Q1/1D).

01/07/2024 Information and consensus document for the diagnostic and therapeutic management of pruritus associated with chronic kidney disease in patients on haemodialysis in Spain

Buades, JM, Figueras-Nart, I, Goicoechea, M, Villanueva, RJS, Serra-Baldrich, E. Information and consensus document for the diagnostic and therapeutic management of pruritus associated with chronic kidney disease in patients on haemodialysis in Spain. NEFROLOGIA. 2024; 44(4)DOI:10.1016/j.nefro.2023.04.006. PMID:39034226. IF:2.600(Q2/4D).

21/06/2024 Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study

Armario-Hita, JC, Pereyra-Rodriguez, JJ, González-Quesada, A, Herranz, P, Suarez, R, Galan-Gutiérrez, M, Rodríguez-Serna, M, de Frutos, JO, Carrascosa, JM, Serra-Baldrich, E, Ara-Martin, M, Figueras-Nart, I, Silvestre, JF, Zaragoza-Ninet, V, Ruiz-Villaverde, R. Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(11)DOI:10.1111/ijd.17344. PMID:39425593. IF:3.200(Q1/3D).

19/06/2024 Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study

Mansilla-Polo, M, Pons-Benavent, M, Fernandez-Crehuet, P, Vilarrasa, E, Albanell-Fernandez, C, Morales-Tedone, E, Rausell-Felix, F, Alcala-Garcia, R, Matellanes-Palacios, M, Martin-Ezquerra, G, Alfageme, F, Ciudad-Blanco, C, Lopez-Villaescusa, MT, Garbayo-Salmons, P, Martorell, A, Escutia-Munoz, B, Navarro-Blanco, F, Martin-Torregrosa, D, Cuenca-Barrales, C, Molina-Leyva, A, Botella-Estrada, R. Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2024; 65(7)DOI:10.1111/ajd.14339. PMID:38895808. IF:1.800(Q3/6D).

11/06/2024 Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study

Chiricozzi, A, Coscarella, G, Puig, L, Vender, R, Yeung, JS, Carrascosa, JM, Piaserico, S, Gisondi, P, Lynde, C, Ferreira, P, Bastos, PM, Dauden, E, Leite, L, Valerio, J, del Alcazar-Viladomiu, E, Vilarrasa, E, Llamas-Velasco, M, Alessandri-Bonetti, M, Messina, F, Bruni, M, Di Brizzi, EV, Ricceri, F, Nidegger, A, Hugo, J, Mufti, A, Daponte, AI, Teixeira, L, Balato, A, Romanelli, M, Prignano, F, Gkalpakiotis, S, Conrad, C, Lazaridou, E, Rompoti, N, Stratigos, AJ, Nogueira, M, Peris, K, Torres, T. Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024; 38(11)DOI:10.1111/jdv.20143. PMID:38860729. IF:8.000(Q1/1D).

10/06/2024 Periungual pyogenic granulomas after ravulizumab therapy in a child with acute myelomonocytic leukemia treated with hematopoietic stem cell transplant

Iznardo, H, López-Torija, I, Mateu-Arrom, L, Escribano-Sanz, P, Puig, L, Roé, E. Periungual pyogenic granulomas after ravulizumab therapy in a child with acute myelomonocytic leukemia treated with hematopoietic stem cell transplant. PEDIATRIC DERMATOLOGY. 2024; 41(5)DOI:10.1111/pde.15675. PMID:38858093. IF:1.200(Q3/7D).

01/06/2024 Duration of smoking cessation in patients with inflammatory bowel disease

González-Muñoza, C, Gely, C, Gordillo, J, Bertoletti, F, Giordano, A, Lopez-Faba, A, García-Planella, E. Duration of smoking cessation in patients with inflammatory bowel disease. Gastroenterologia y Hepatologia. 2024; 47(6)DOI:10.1016/j.gastrohep.2023.11.002. PMID:37977427. IF:1.900(Q3/7D).

01/06/2024 Italian S3-Guideline on the treatment ofAtopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)

Argenziano, G, Cusano, F, Corazza, M, Amato, S, Amerio, P, Naldi, L, Patruno, C, Pigatto, PD, Quaglino, P, Gisondi, P, Chiricozzi, A, Tonon, F, Stingeni, L, Calzavara-Pinton, P, Wollenberg, A, Kinberger, M, Arents, BW, Aszodi, N, Valle, GLA, Barbarot, S, Bieber, T, Brough, HA, Christen-Zäch, S, Deleuran, M, Dittmann, M, Dressler, C, Fink-Wagner, AH, Fosse, N, Gáspár, K, Gerbens, LA, Gieler, U, Girolomoni, G, Gregoriou, S, Mortz, CG, Nast, A, Nygaard, U, Redding, M, Rehbinder, EM, Ring, J, Rossi, M, Serra-Baldrich, E, Simon, D, Szalai, ZZ, Szepietowski, JC, Torrelo, A, Werfel, T, Flohr, C. Italian S3-Guideline on the treatment ofAtopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA). Italian Journal of Dermatology and Venereology. 2024; 159(3)DOI:10.23736/S2784-8671.24.07667-9. PMID:38727635. IF:2.600(Q2/4D).

01/06/2024 Italian S3-Guideline on the treatment ofAtopic EczemaPart 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society ofAllergological and Environmental Dermatology (SIDAPA)

Argenziano, G, Cusano, F, Corazza, M, Amato, S, Amerio, P, Naldi, L, Patruno, C, Pigatto, PD, Quaglino, P, Gisondi, P, Chiricozzi, A, Tonon, F, Stingeni, L, Calzavara-Pinton, P, Wollenberg, A, Kinberger, M, Arents, BW, Aszodi, N, Avila Valle, GL, Barbarot, S, Bieber, T, Brough, H, Christen-Zäch, S, Deleuran, M, Dittmann, M, Dressler, C, Fink-Wagner, AH, Fosse, N, Gáspár, K, Gerbens, LA, Gieler, U, Girolomoni, G, Gregoriou, S, Mortz, CG, Nast, A, Nygaard, U, Redding, M, Rehbinder, EM, Ring, J, Rossi, M, Serra-Baldrich, E, Simon, D, Szalai, ZZ, Szepietowski, JC, Torrelo, A, Werfel, T, Flohr, C. Italian S3-Guideline on the treatment ofAtopic EczemaPart 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society ofAllergological and Environmental Dermatology (SIDAPA). Italian Journal of Dermatology and Venereology. 2024; 159(3)DOI:10.23736/S2784-8671.24.07664-3. PMID:38727633. IF:2.600(Q2/4D).